CD44 and neoplasm: Although most conventional PIT experiments and clinical trials have utilised full antibodies,1,3,21,37 their large molecular size can result in significant variations in tissue and plasma concentrations.38, 39, 40 Our study has shown that the local administration of CD44-IR700 increases the proportion of tumour cells bound by the conjugate and inhibits tumour growth upon NIR light irradiation.